AbbVie saw the highest growth of 1.08% in patent filings and 1.54% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 1.08% and grants by 1.54%. GlobalData’s DataBook provides a comprehensive analysis of AbbVie‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
AbbVie has been focused on protecting inventions in United States(US) with 85 publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 44% filings and 23% grants. The United States(US), European Patent Office(EPO), South Korea(KR), and Japan(JP) patent Office are among the top ten patent offices where AbbVie is filings its patents. Among the top granted patent authorities, AbbVie has 23% of its grants in United States(US), 9% in South Korea(KR) and 9% in Japan(JP).
Roche could be the strongest competitor for AbbVie
In terms of grant share, AbbVie stands in seventh position among its competitors. AbbVie and Roche secured the top positions according to recent patent publication data.
Patents related to rare diseases and nanomedicine lead AbbVie's portfolio
AbbVie has the highest number of patents in rare diseases followed by, nanomedicine and climate change. For rare diseases, nearly 51% of patents were filed and 56% of patents were granted in Q2 2024.
Rheumatoid arthritis related patents lead AbbVie portfolio followed by general surgery devices, and alzheimer's disease
AbbVie has highest number of patents in rheumatoid arthritis followed by general surgery devices, alzheimer's disease, lymphoma, and melanoma. For rheumatoid arthritis, nearly 1% of patents were filed and 1% of patents were granted in Q2 2024.
For comprehensive analysis of AbbVie's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
